Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR 4/NF-κB pathway and protecting the intestinal barrier

Interleukin-1 receptor-associated kinase 1/4 (IRAK1/4) is the main kinase of the toll-like receptor (TLR)-mediated pathway, considered a new target for treating inflammatory diseases. Studies showed a significant correlation between TLRs and inflammatory responses in ulcerative colitis. Therefore, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Bo, Li, Xiangjie, Zhou, Linxiang, Qiao, Yuqing, Wu, Jing, Zha, Lanlan, Liu, Peilu, Peng, Shuai, Wu, Baixin, Yu, Xiaoyun, Shen, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589302/
https://www.ncbi.nlm.nih.gov/pubmed/35699749
http://dx.doi.org/10.17305/bjbms.2022.7348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589302/
https://www.ncbi.nlm.nih.gov/pubmed/35699749
http://dx.doi.org/10.17305/bjbms.2022.7348

Ejemplares similares